Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Study of Irbersartan for the Early Treatment of Severe Sepsis Patients

NCT01992796 is registered in ClinicalTrials.gov with University of Salerno as lead sponsor.

NCT NCT01992796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01992796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Study of Irbersartan for the Early Treatment of Severe Sepsis Patients
Lead sponsor
University of Salerno
Phase
Phase 3
Overall status
Unknown status
Start date
January 31, 2014
Completion date
January 31, 2017
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

severe sepsis